A portrait of tissue phosphoprotein stability in the clinical tissue procurement process
about
Guidelines for the use and interpretation of assays for monitoring autophagyImpact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissueThe impact of biosampling procedures on molecular data interpretationThe procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settingsOne-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimensReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseReverse phase protein microarrays advance to use in clinical trialsProfiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyPhosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology.Spatial normalization of reverse phase protein array data.Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survivalA tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescence.Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling.Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinomaLaser capture microdissection for protein and NanoString RNA analysisMolecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterationsThe use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease.Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum.Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues.Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue.A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.Biospecimen Reporting for Improved Study Quality.Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variablesBiospecimen reporting for improved study quality (BRISQ)Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneityFunctional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Immunohistochemistry of colorectal cancer biomarker phosphorylation requires controlled tissue fixation.Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.Preserving protein profiles in tissue samples: differing outcomes with and without heat stabilization.Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia.A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.
P2860
Q21996341-81A51662-DDDE-40E0-A18D-7C8A88233354Q26851269-D4196AA1-0D58-40A3-B70A-0DDCDBBB5AB8Q26991764-7E0D11D5-9BA1-4574-824B-3A0A88ACA62AQ27001144-4A5D7A6F-4788-4AC1-8073-53010A5EABDAQ27323289-F03E2704-5FC3-44CC-AC6C-49A79C3120B0Q28083256-7D98174E-471A-4A3D-AA7A-F5AA55E0D886Q28384553-BAC4D061-7AAD-4DC1-ABA9-DEA49EAB9C67Q30274823-87628BDF-0A0B-4893-B916-A28CE9917CDDQ30438965-0F681C0F-BDB1-4694-B039-5BC5AFDB1F7EQ30450696-19621A08-B52E-429E-9675-1E15EA669370Q30877911-A14ACD42-88FA-4FA6-926E-0DA32CD2BC1DQ33565313-6EC92318-8AC7-40C2-8AC7-4C74A6CBD125Q33649620-7BD0CFC1-F0B8-496A-B315-D55DF8412287Q33827011-E30BFDD4-4CC3-41F0-BFCD-62C66DA33987Q33850616-57658AF4-565F-4EA6-BC68-F136A4B3D40FQ33850627-DEFB2E58-7369-4122-99EF-22448E71D595Q34069349-0711E763-6373-46EA-8125-0D9B03B6BDAEQ34093266-F96E0B06-EADC-479A-A73D-3AACAB78E945Q34149563-AA258174-CC56-44E9-9150-1D06B64FB829Q34420593-C850E6B3-F17B-4DC6-9945-34D36A85AAD2Q34425869-AFE750DF-C5C7-4B0A-A483-6F2A1D1824E2Q34436356-D59F57F0-2ABB-4A2E-9114-A2B3EF2E7981Q34440079-A1E7A49B-6F9A-4A08-9BAB-D0E622610AC6Q34483187-9BE799BB-B504-411E-BD8D-A3948B1BFCCAQ34566972-8B978843-3E9F-4DDC-8675-761335485BB8Q34670535-ADF16A7E-B867-4F3D-8346-B99E8D605AC2Q34693949-26AC81D6-81A9-4524-B71A-29421BF4AB30Q34956722-61852B38-4B62-4AE7-8B1F-802658701478Q35049524-9F7D4B3C-AED8-487D-AFFC-83B6B741FA06Q35058975-3FF3BB60-F392-4270-A9F1-FF674091B7CFQ35125775-4460E6D0-3165-411E-87FD-6282FC19764FQ35131931-FF9373A8-777A-42D9-8734-FE5B210602F9Q35203154-C744E686-C8AD-4E7B-B55C-A7ED54D8EE62Q35251771-3F46F427-E89F-4E40-8228-0570A1B98A62Q35328194-E752BF4C-C20D-43AE-B73C-794C1316A5A0Q35436560-9A117BB3-2842-40FC-8AEE-F01FC54B6EA6Q35560129-2FF4195C-F317-4098-924D-92BB2DD3789BQ35821741-3D9B8E46-1B59-46A9-B75F-20F1CA4CF08BQ36018192-1F5D31AA-8A99-406E-A966-5BFD22E742D3Q36186223-D9B817E7-664D-454C-BFB5-8337B21F6551
P2860
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process
@en
type
label
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process
@en
prefLabel
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process
@en
P2093
P2860
P1476
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process
@en
P2093
Amy J VanMeter
Barbara Merritt
David H Geho
Emanuel F Petricoin
Jianghong Deng
Joel Sennesh
Kirsten H Edmiston
Lance A Liotta
Lucia Pastore
Manuela Sciro
P2860
P304
P356
10.1074/MCP.M700596-MCP200
P577
2008-07-30T00:00:00Z